Rapport Therapeutics, Inc. (RAPP)
27.84
-0.83
(-2.90%)
USD |
NASDAQ |
Mar 13, 16:00
27.85
+0.01
(+0.04%)
After-Hours: 20:00
Rapport Therapeutics Market Cap : 1.016B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bridgebio Oncology Therapeutics, Inc. | 727.10M |
| ACADIA Pharmaceuticals, Inc. | 3.514B |
| Agenus, Inc. | 112.04M |
| Alnylam Pharmaceuticals, Inc. | 41.57B |
| Savara, Inc. | 1.068B |
Market Cap Related Metrics
| PEG Ratio | -0.2873 |
| Price to Book Value | 2.097 |
| Price | 27.84 |
| Earnings Yield | -10.29% |
| PEGY Ratio | -0.2873 |